|
[Related PubMed/MEDLINE]
Total Number of Papers: 42
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2018 |
Characterization of Corneal Donor Tissue Lesions by Anterior Segment Optical Coherence Tomography Compared With Eye Bank Technician Slit-Lamp Examination. |
OCT |
| 2 |
2017 |
Mechanical exposure of ophthalmic surgeons: a quantitative ergonomic evaluation of indirect ophthalmoscopy and slit-lamp biomicroscopy. |
VR |
| 3 |
2015 |
In vivo corneal confocal microscopic analysis in patients with keratoconus. |
IVCM |
| 4 |
2015 |
Staphylococcus Alpha-Toxin Action on the Rabbit Iris: Toxic Effects and Their Inhibition. |
CD-cholesterol |
| 5 |
2013 |
Moxifloxacin as postoperative prophylaxis for Enterococcus faecalis-induced endophthalmitis after cataract surgery in aphakic rabbits. |
ERG, LVFX, MFLX, MICs |
| 6 |
2013 |
Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor. |
p.i, PASP |
| 7 |
2013 |
The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model. |
HPMC, p.i, TFT |
| 8 |
2012 |
Staphylococcus aureus infection of the rabbit cornea following topical administration. |
PMN |
| 9 |
2011 |
Diverse virulence of Staphylococcus aureus strains for the conjunctiva. |
CFU, p.i |
| 10 |
2011 |
The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis. |
CFU, p.i |
| 11 |
2010 |
Moxifloxacin and cholesterol combined treatment of pneumococcal keratitis. |
CFU, MICs, MPO, p.i, PBS |
| 12 |
2010 |
The effectiveness of an improved combination therapy for experimental Staphylococcus aureus keratitis. |
CFUs, MRSA, MSSA, p.i |
| 13 |
2009 |
Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus. |
CD, CFU, p.i, PBS |
| 14 |
2009 |
Development of a Streptococcus pneumoniae keratitis model in mice. |
CFU, p.i |
| 15 |
2009 |
Properties of PASP: a Pseudomonas protease capable of mediating corneal erosions. |
PI, PMN |
| 16 |
2008 |
A comparison of pneumolysin activity and concentration in vitro and in vivo in a rabbit endophthalmitis model. |
CFU, OD |
| 17 |
2008 |
The significance of Vogt's striae in keratoconus as evaluated by in vivo confocal microscopy. |
IVCM, SE |
| 18 |
2008 |
Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action. |
BP, HR, IOP, WIN |
| 19 |
2007 |
Age-related differences in rabbits during experimental Staphylococcus aureus keratitis. |
CFUs, HU, p.i, PMNs |
| 20 |
2007 |
Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea. |
CFUs, MIC |
| 21 |
2007 |
Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida. |
CFU, p.i |
| 22 |
2006 |
Apolipoprotein E modulates establishment of HSV-1 latency and survival in a mouse ocular model. |
p.i, TG |
| 23 |
2006 |
Different amino acid substitutions at the same position in rhodopsin lead to distinct phenotypes. |
BCVA, DA, ERG, GP |
| 24 |
2005 |
Effects of toxin production in a murine model of Staphylococcus aureus keratitis. |
CFU, MPO |
| 25 |
2005 |
Ocular virulence of capsule-deficient streptococcus pneumoniae in a rabbit keratitis model. |
CFUs |
| 26 |
2004 |
Susceptibility of aged mice to Staphylococcus aureus keratitis. |
p.i |
| 27 |
2003 |
A new topical model of Staphylococcus corneal infection in the mouse. |
CFU, MPO, PMNs |
| 28 |
2003 |
Changes in gene expression in latent HSV-1-infected rabbit trigeminal ganglia following epinephrine iontophoresis. |
HSV-1, mRNA |
| 29 |
2002 |
Corneal pathogenesis of Staphylococcus aureus strain Newman. |
CFU, hla |
| 30 |
2002 |
Corneal virulence of Staphylococcus aureus in an experimental model of keratitis. |
CFU |
| 31 |
2001 |
Increased severity of HSV-1 keratitis and mortality in mice lacking the 2-5A-dependent RNase L gene. |
HSV-1, p.i |
| 32 |
2001 |
Phospholipase A(2) in rabbit tears: a host defense against Staphylococcus aureus. |
CFU, PLA2 |
| 33 |
2001 |
Staphylococcus corneal virulence in a new topical model of infection. |
CFUs |
| 34 |
1999 |
Serratia marcescens keratitis: strain-specific corneal pathogenesis in rabbits. |
--- |
| 35 |
1998 |
Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model. |
CFU, ciprofloxacin-PSS, PSS |
| 36 |
1998 |
Epithelial permeability reflects subclinical effects of contact lens wear. |
CL, CT |
| 37 |
1997 |
Histopathological studies of staphylococcal alpha-toxin: effects on rabbit corneas. |
PBS, PMN |
| 38 |
1995 |
Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis. |
CFU |
| 39 |
1995 |
Growth and virulence of a complement-activation-negative mutant of Streptococcus pneumoniae in the rabbit cornea. |
CFU |
| 40 |
1993 |
Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen. |
--- |
| 41 |
1993 |
Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. |
PMN |
| 42 |
1992 |
Confirmation of the role of pneumolysin in ocular infections with Streptococcus pneumoniae. |
--- |
|
A Search Service for Abbreviation / Long Form
